Strongest Current Evidence CagriSema REDEFINE 1 and REDEFINE 2 are completed phase 3 trials published in NEJM with over 4,600 participants
In a sample of 1,092 men and women without dementia followed for an average of 10 years, those with higher plasma homocysteine levels at baseline had a significantly higher risk of developing Alzheimer's disease and other types of dementia
Do I need different supplements for tirzepatide versus semaglutide
Weight loss medications, such as Ozempic, Wegovy, and Mounjaro, are a type of drug originally designed to help people with type 2 diabetes manage their blood sugar 1,4
The primary outcome of the trial is to determine dose-limiting toxicities during the first two cycles of therapy while secondary outcomes involve the identification of treatment-emergent adverse events (TEAEs) and objective tumor response
Copyright 2023 HealthDay